Melanocytes-A novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy

Journal of Cellular Physiology

Volumn 228, Issue 6, 2013, Pages 1323-1331

  Pellegrini, Camilla ^a   Zulian, Alessandra ^b   Gualandi, Francesca ^a   Manzati, Elisa ^a   Merlini, Luciano ^c   Michelini, Maria E ^a   Benassi, Luisa ^d   Marmiroli, Sandra ^d   Ferlini, Alessandra ^a   Sabatelli, Patrizia ^e   Bernardi, Paolo ^b   Maraldi, Nadir M ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; DYSTROPHIN; OLIGOMYCIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TETRAMETHYLRHODAMINE METHYL ESTER; UTROPHIN;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MELANOCYTE; MITOCHONDRION; MORPHOLOGICAL TRAIT; MYOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SKIN BIOPSY; WESTERN BLOTTING;

BIOPSY; BLOTTING, NORTHERN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELLS, CULTURED; DYSTROPHIN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; OLIGOMYCINS; RHODAMINES; SKIN; TIME FACTORS; UTROPHIN;

EID: 84874199731     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24290     Document Type: Article

References (43)

1. Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C, Mattioli E, Gualandi F, Ferlini A, Merlini L, Maraldi NM, Bonaldo P, Bernardi P. 2007. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci USA 104:991-996.
2. Angelin A, Bonaldo P, Bernardi P. 2008. Altered threshold of the mitochondrial permeability transition pore in Ullrich congenital muscular dystrophy. Biochim Biophys Acta 1777:893-896.
3. Arechavala-Gomeza V, Graham IR, Popplewell LJ, Adams AM, Aartsma-Rus A, Kinali M, Morgan JE, van Deutekom JC, Wilton SD, Dickson G, Muntoni F. 2007. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum Gene Ther 18:798-810.
4. Baghdiguian S, Martin M, Richard I, Pons F, Astier C, Bourg N, Hay RT, Chemaly R, Halaby G, Loiselet J, Anderson LV, Lopez deMunain A, Fardeau M, Mangeat P, Beckmann JS, Lefranc G. 1999. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med 5:503-511.
5. Bar S, Barnea E, Levy Z, Neuman S, Yaffe D, Nudel U. 1990. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J 272:557-560.
6. Barresi R, Campbell KP. 2006. Dystroglycan: From biosynthesis to pathogenesis of human disease. J Cell Sci 119:199-207.
7. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. 1999. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 264:687-701.
8. Byers TJ, Lidov HG, Kunkel LM. 1993. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4:77-81.
9. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN. 1995. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 4:837-842.
10. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P. 1995. Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol 130:79-91.
11. Ferlini A, Sabatelli P, Fabris M, Bassi E, Falzarano S, Vattemi G, Perrone D, Gualandi F, Maraldi NM, Merlini L, Sparnacci K, Laus M, Caputo A, Bonaldo P, Braghetta P, Rimessi P. 2010. Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. Gene Ther 17:432-438.
12. Gerdes J, Schwab U, Lemke H, Stein H. 1983. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20.
13. Herzog C, Has C, Franzke CW, Echtermeyer FG, Schlotzer-Schrehardt U, Kroger S, Gustafsson E, Fassler R, Bruckner-Tuderman L. 2004. Dystroglycan in skin and cutaneous cells: Beta-subunit is shed from the cell surface. J Invest Dermatol 122:1372-1380.
14. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P. 2003. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 35:367-371.
15. Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P. 1993. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 52:119-128.
16. Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH. 1992. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): Evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 50:950-959.
17. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Müller CR, Lindlöf M, Kaariainen H. 1989. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am J Hum Genet 45:498-506.
18. Kormos B, Belso N, Bebes A, Szabad G, Bacsa S, Szell M, Kemeny L, Bata-Csorgo Z. 2011. In vitro dedifferentiation of melanocytes from adult epidermis. PLoS ONE 6:e17197.
19. Korner H, Epanchintsev A, Berking C, Schuler-Thurner B, Speicher MR, Menssen A, Hermeking H. 2007. Digital karyotyping reveals frequent inactivation of the dystrophin/DMD gene in malignant melanoma. Cell Cycle 6:189-198.
20. Masuda-Hirata M, Suzuki A, Amano Y, Yamashita K, Ide M, Yamanaka T, Sakai M, Imamura M, Ohno S. 2009. Intracellular polarity protein PAR-1 regulates extracellular laminin assembly by regulating the dystroglycan complex. Genes Cells 14:835-850.
21. Menazza S, Blaauw B, Tiepolo T, Toniolo L, Braghetta P, Spolaore B, Reggiani C, Di Lisa F, Bonaldo P, Canton M. 2010. Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet. 19:4207-4215.
22. Merlini L, Angelin A, Tiepolo T, Braghetta P, Sabatelli P, Zamparelli A, Ferlini A, Maraldi NM, Bonaldo P, Bernardi P. 2008. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 105:5225-5229.
23. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. 2002. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422.
24. Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, Sweeney HL, Robbins J, Molkentin JD. 2008. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 14:442-447.
25. Muntoni F, Torelli S, Ferlini A. 2003. Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurol 2:731-740.
26. Ognibene A, Sabatelli P, Petrini S, Squarzoni S, Riccio M, Santi S, Villanova M, Palmeri S, Merlini L, Maraldi NM. 1999. Nuclear changes in a case of X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve 22:864-869.
27. Pauly M, Daussin F, Burelle Y, Li T, Godin R, Fauconnier J, Koechlin-Ramonatxo C, Hugon G, Lacampagne A, Coisy-Quivy M, Liang F, Hussain S, Matecki S, Petrof BJ. 2012. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol 181:583-592.
28. Petrof BJ. 2002. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 81:S162-S174.
29. Pinon P, Wehrle-Haller B. 2011. Integrins: Versatile receptors controlling melanocyte adhesion, migration and proliferation. Pigment Cell Melanoma Res 24:282-294.
30. Rasola A, Bernardi P. 2011. Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium 50:222-233.
31. Reutenauer J, Dorchies OM, Patthey-Vuadens O, Vuagniaux G, Ruegg UT. 2008. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br J Pharmacol 155:574-584.
32. Sabatelli P, Columbaro M, Mura I, Capanni C, Lattanzi G, Maraldi NM, Beltràn-Valero deBarnabè D, van Bokoven H, Squarzoni S, Merlini L. 2003. Extracellular matrix and nuclear abnormalities in skeletal muscle of a patient with Walker-Warburg syndrome caused by POMT1 mutation. Biochim Biophys Acta 1638:57-62.
33. Santiago-Walker A, Li L, Haass NK, Herlyn M. 2009. Melanocytes: From morphology to application. Skin Pharmacol Physiol 22:114-121.
34. Sewry CA, Philpot J, Sorokin LM, Wilson LA, Naom I, Goodwin F, D'Alessandro M, Dubowitz V, Muntoni F. 1996. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 347:582-584.
35. Tanveer N, Sharma MC, Sarkar C, Gulati S, Kalra V, Singh S, Bhatia R. 2009. Diagnostic utility of skin biopsy in dystrophinopathies. Clin Neurol Neurosurg 111:496-502.
36. Tiepolo T, Angelin A, Palma E, Sabatelli P, Merlini L, Nicolosi L, Finetti F, Braghetta P, Vuagniaux G, Dumont JM, Baldari CT, Bonaldo P, Bernardi P. 2009. The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice. Br J Pharmacol 157:1045-1052.
37. Trimarchi F, Favaloro A, Fulle S, Magaudda L, Puglielli C, Di Mauro D. 2006. Culture of human skeletal muscle myoblasts: Timing appearance and localization of dystrophin-glycoprotein complex and vinculin-talin-integrin complex. Cells Tissues Organs 183:87-98.
38. Waite A, Brown SC, Blake DJ. 2012. The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci 35:487-496.
39. Wissing ER, Millay DP, Vuagniaux G, Molkentin JD. 2010. Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. Neuromuscul Disord. 20:753-760.
40. Wrogemann K, Pena SD. 1976. Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Lancet 1:672-674.
41. Yamaguchi Y, Brenner M, Hearing VJ. 2007. The regulation of skin pigmentation. J Biol Chem 282:27557-27561.
42. Yokota T, Lu QL, Morgan JE, Davies KE, Fisher R, Takeda S, Partridge TA. 2006. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci 119:2679-2687.
43. Zoratti M, Szabo I. 1995. The mitochondrial permeability transition. Biochim Biophys Acta 1241:139-176.